All News about Supernus Pharm
Supernus Announces Second Quarter 2024 Financial Results
August 06, 2024
Via GlobeNewswire
Recap: Supernus Pharmaceuticals Q4 Earnings
February 27, 2024
Via Benzinga
Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device
August 01, 2024
Via GlobeNewswire
Supernus Pharmaceuticals Faces Second FDA Rejection For Investigational Device For Parkinson's Disease
April 08, 2024
Via Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 08, 2024
Via Benzinga
Supernus Provides Regulatory Update for SPN-830
April 08, 2024
Via GlobeNewswire
Supernus to Participate in Two Upcoming Investor Conferences
March 06, 2024
Via GlobeNewswire
Via GlobeNewswire
Supernus Announces Fourth Quarter and Full Year 2023 Financial Results
February 27, 2024
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.